Skip to main content
MEDICOX Co., Ltd. logo

MEDICOX Co., Ltd. — Investor Relations & Filings

Ticker · 054180 ISIN · KR7054180005 KO Manufacturing
Filings indexed 803 across all filing types
Latest filing 2023-08-14 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 054180

About MEDICOX Co., Ltd.

https://www.medicox.co.kr

MEDICOX Co., Ltd., formerly ChoongAng Ocean Co Ltd, is a company engaged in the manufacture and sale of shipbuilding materials and equipment. Its primary products are structural components for large vessels, including curved blocks, bow and stern sections, propeller bosses, and engine room parts. In addition to its core shipbuilding business, the company is diversifying into the biopharmaceutical sector, focusing on new drug development and the commercialization of pharmaceutical products.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Major Report' (주요사항보고서) concerning a capital increase (유상증자). Specifically, it is an amendment (정정신고) to a previous filing, announcing the cancellation of a previously decided third-party capital increase. Since this relates to changes in capital structure and share issuance, it falls under the 'Share Issue/Capital Change' category.
2023-08-14 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KRX) regarding a 'Major Report' (주요사항보고서) concerning a capital increase (유상증자). Specifically, it is a correction report (정정신고) announcing the cancellation of a previously decided third-party capital increase. Since this relates to changes in capital structure and financing activities, it falls under the 'Capital/Financing Update' category.
2023-08-14 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) from Medicox regarding the cancellation of a previously announced convertible bond issuance. It details the correction of a prior filing (dated 2022-12-27) to reflect the withdrawal of the issuance. Since this relates to financing activities and capital structure changes (specifically the cancellation of a debt instrument), it falls under the 'Capital/Financing Update' category.
2023-08-14 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from a Korean company (Medicox) regarding the cancellation of a previously announced convertible bond issuance. This falls under capital structure changes and financing updates. Since it specifically details the cancellation of a financial instrument issuance, it is classified as a Capital/Financing Update.
2023-08-14 Korean
기타주요경영사항(제3자배정 유상증자 결정 2건 및 제20회, 제21회 전환사채 발행결정 철회의 건)
Share Issue/Capital Change Classification · 100% confidence The document is an official regulatory filing from Medicox regarding the cancellation of previously announced third-party capital increases (share issuance) and convertible bond issuances. Since the document details changes to the company's capital structure and financing plans, it falls under the 'Capital/Financing Update' category.
2023-08-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '주식회사 메디콕스' covering the period from 2023-01-01 to 2023-06-30. It contains detailed corporate information, financial data, and management disclosures, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2023
2023-08-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.